Memory Reorganization in Mesial Temporal Lobe Epilepsy
Summary
This study aims to explore how memory works in people with temporal lobe epilepsy, a condition that causes seizures and is frequently accompanied by memory problems. For some, surgery to remove the part of the brain causing seizures may help, but it does not always work, and memory can get worse afterward. We aim to use magnetic resonance imaging to image the brain participants are completing memory tasks, which will reveal the areas of the brain responsible for memory. This knowledge could help doctors decide which epilepsy patient might benefit from surgery, how to plan surgery to minimize memory loss, and set realistic expectations for patients about their memory after the procedure.
As part of the study, patient participants and healthy controls will look at images of faces and scenes as well as words inside a magnetic resonance scanner. Still inside the scanner, participants will have to attempt to remember the images and words you saw after 20 minutes. This way, we will be able to see the areas in the brain responsible for memorizing as well as remembering. We will also ask participants to complete a quick memory test outside of the scanner.
Eligibility
Eligible ages: 18 to 75
Accepts healthy participants: Yes
Inclusion criteria:
For healthy controls, we are recruiting adults between the ages of 18 to 75 who have no preexisting psychiatric or neurological conditions.
For patient participants, we are recruiting adults between the ages of 18 to 75 who have a diagnosis of left or right temporal lobe epilepsy.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
If you are interested in learning more about this study, please contact Shehab Elaktash for more information.
Principal investigator:
Paolo Federico
Clinical trial:
No
REB-ID:
REB25-0467